Literature DB >> 34562188

Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life.

Eva K Fenwick1,2, Ester P X Lee1, Ryan E K Man1,2, Kam Chun Ho1,3, Raymond P Najjar1,2, Dan Milea1, Kelvin Y C Teo1,2, Anna C S Tan1,2, Shu Yen Lee1,2, Ian Yew San Yeo1,2, Gavin S W Tan1,2, Ranjana Mathur1,2, Tien Yin Wong1,2, Chui Ming Gemmy Cheung1, Ecosse L Lamoureux4,5,6.   

Abstract

PURPOSE: We are developing an age-related macular degeneration (AMD) health-related quality of life (HRQoL) item bank, applicable to Western and Asian populations. We report primarily on content generation and refinement, but also compare the HRQoL issues reported in our study with Western studies and current AMD-HRQoL questionnaires.
METHODS: In this cross-sectional, qualitative study of AMD patients attending the Singapore National Eye Centre (May-December 2019), items/domains were generated from: (1) AMD-specific questionnaires; (2) published articles; (3) focus groups/semi-structured interviews with AMD patients (n = 27); and (4) written feedback from retinal experts. Following thematic analysis, items were systematically refined to a minimally representative set and pre-tested using cognitive interviews with 16 AMD patients.
RESULTS: Of the 27 patients (mean ± standard deviation age 67.9 ± 7.0; 59.2% male), 18 (66.7%), two (7.4%), and seven (25.9%) had no, early-intermediate, and late/advanced AMD (better eye), respectively. Whilst some HRQoL issues, e.g. activity limitation, mobility, lighting, and concerns were similarly reported by Western patients and covered by other questionnaires, others like anxiety about intravitreal injections, work tasks, and financial dependency were novel. Overall, 462 items within seven independent HRQoL domains were identified: Activity limitation, Lighting, Mobility, Emotional, Concerns, AMD management, and Work. Following item refinement, items were reduced to 219, with 31 items undergoing amendment.
CONCLUSION: Our 7-domain, 219-item AMD-specific HRQoL instrument will undergo psychometric testing and calibration for computerized adaptive testing. The future instrument will enable users to precisely, rapidly, and comprehensively quantify the HRQoL impact of AMD and associated treatments, with item coverage relevant across several populations.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Age-related macular degeneration; Computerized adaptive testing; Item bank; Qualitative; Quality of life

Mesh:

Year:  2021        PMID: 34562188     DOI: 10.1007/s11136-021-02989-w

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

1.  Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).

Authors:  Jan Mitchell; Clare Bradley
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

Review 2.  What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research.

Authors:  Amy E Bennion; Rachel L Shaw; Jonathan M Gibson
Journal:  Soc Sci Med       Date:  2012-05-21       Impact factor: 4.634

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

Review 4.  Age-related macular degeneration.

Authors:  Laurence S Lim; Paul Mitchell; Johanna M Seddon; Frank G Holz; Tien Y Wong
Journal:  Lancet       Date:  2012-05-05       Impact factor: 79.321

5.  Value-based Healthcare: Patient-reported Outcomes in Clinical Decision Making.

Authors:  Judith F Baumhauer; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2016-04-06       Impact factor: 4.176

6.  The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment.

Authors:  David Cella; Richard Gershon; Jin-Shei Lai; Seung Choi
Journal:  Qual Life Res       Date:  2007-03-31       Impact factor: 4.147

7.  Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire.

Authors:  Robert P Finger; Eva Fenwick; Konrad Pesudovs; Manjula Marella; Ecosse L Lamoureux; Frank G Holz
Journal:  Ophthalmology       Date:  2012-09-08       Impact factor: 12.079

Review 8.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Authors:  Wan Ling Wong; Xinyi Su; Xiang Li; Chui Ming G Cheung; Ronald Klein; Ching-Yu Cheng; Tien Yin Wong
Journal:  Lancet Glob Health       Date:  2014-01-03       Impact factor: 26.763

9.  +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.

Authors:  Jan Mitchell; James S Wolffsohn; Alison Woodcock; Stephen J Anderson; Carolyn V McMillan; Timothy Ffytche; Martin Rubinstein; Winfried Amoaku; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2005-04-14       Impact factor: 3.186

Review 10.  How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review.

Authors:  Deanna J Taylor; Angharad E Hobby; Alison M Binns; David P Crabb
Journal:  BMJ Open       Date:  2016-12-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.